Evive Biotech
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Develops novel biologic and small molecule therapies for metabolic diseases like diabetes and obesity.
Metabolic
Technology Platform
Integrated discovery platform for identifying novel targets and developing both biologic and small molecule drug candidates for metabolic disorders.
Opportunities
Addressing the massive, growing global patient population with diabetes, obesity, and related liver diseases.
Risk Factors
Clinical and commercial risk of differentiating its candidates against highly effective established and emerging therapies.
Competitive Landscape
Enters a fiercely competitive metabolic market dominated by global giants like Novo Nordisk and Eli Lilly.